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Abstract: Diabetes patients are known to have a worse quality of life than individuals without diabetes. They also have an 
increased risk for depressive symptoms, which may have an additional negative effect on their quality of life. This sys-
tematic review summarizes the current knowledge on the association between depressive symptoms and quality of life in 
individuals with diabetes. A systematic literature search using MEDLINE, Psychinfo, Social SciSearch, SciSearch and 
EMBASE was conducted from January 1990 until September 2007. We identified studies that compared quality of life be-
tween diabetic individuals with and without depressive symptoms. Twenty studies were identified, including eighteen 
cross-sectional and two longitudinal studies. Quality of life was measured as generic, diabetes specific and domain spe-
cific quality of life. All studies reported a negative association between depressive symptoms and at least one aspect of 
quality of life in people with diabetes. Diabetic individuals with depressive symptoms also had a severely lower diabetes 
specific quality of life. Generic and domain specific quality of life were found to be mild to moderately lower in the pres-
ence of depressive symptoms. Therefore, increased awareness and monitoring for depression is needed within different 
diabetes care settings.  
Keywords: Diabetes, Depression, Quality of life, Review. 
INTRODUCTION 
Diabetes is a serious health problem in the Western 
world. According to the International Diabetes Federation, 
189 million individuals have diabetes world wide [1]. The 
prevalence of diabetes in Western societies is rapidly rising; 
worldwide the number of individuals with diabetes is ex-
pected to have doubled in 2025. Diabetes is frequently ac-
companied by serious short term complications such as hy-
poglycaemia, but also by disabling long term complications 
like cardiovascular disease, neuropathy, nephropathy and 
retinopathy. Less known is the increased risk for depression: 
individuals with diabetes have a two-fold increased risk for 
depression, affecting approximately 1 in every five diabetes 
patients [2, 3]. Depressive symptoms are particularly com-
mon among diabetes patients with co-morbid health prob-
lems, as compared to patients with diabetes alone [4]. 
Diabetes care mainly consists of self care. Diabetes pa-
tients themselves have to regulate their blood glucose levels 
by monitoring their blood glucose levels and by balancing 
their food intake, physical activities and their intake of oral 
hypoglycaemic agents and/or insulin. The overall treatment 
goal is to prevent acute and chronic complications, while 
preserving a good quality of life. Several studies have shown 
that the quality of life in diabetes is decreased as compared  
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to individuals without diabetes [5-7]. Furthermore, the pres-
ence of diabetic complications has an additional negative 
impact on quality of life [5, 8]. Depressive symptoms are 
known to have a considerable impact on quality of life as 
well [6]. The co-occurrence of depressive symptoms and 
diabetes may even further decrease quality of life. When this 
is indeed the case, this stressed the importance of an in-
creased awareness and treatment of depressive symptoms 
within diabetes care.  
Depressive symptoms may thus be an important determi-
nant of quality of life in diabetes. Therefore, a study on the 
impact of depressive symptoms on quality of life in indi-
viduals with diabetes is warranted. This systematic review 
aims to describe the current knowledge on the association of 
depressive symptoms with various aspects of quality of life 
in individuals with diabetes. 
METHODS 
A literature search using the databases MEDLINE, Psy-
chinfo, Social SciSearch, SciSearch and EMBASE was per-
formed to identify published studies that evaluate the effect 
of depressive symptoms on quality of life in adult individu-
als with diabetes. Only full papers were included in this re-
view, (meeting) abstracts and reviews were not included. 
The terms diabetes or diabetic* or iddm (insulin dependent 
diabetes mellitus) or niddm (non-insulin dependent diabetes 
mellitus) or diabetes mellitus were combined with depres-
sion or depressive or depressed mood or depressed patients 
or  depressed subjects or depressed women or  dysthym* or 
dysthymic disorder and with quality of life or activities of Diabetes, Depression and Quality of Life  Current Diabetes Reviews, 2009, Vol. 5, No. 2    113 
 
daily living. The search was limited to articles in English, 
published between January 1990 and September 2007. The 
resulting publications were screened for relevance, first by 
title and then by abstract (by MTS). To be included, studies 
had to compare quality of life in diabetic individuals with or 
without depression or depressive symptoms. Reference lists 
of the relevant studies were examined to obtain additional 
reports. 
Quality of Life 
“Quality of life” represents an individual’s perception on 
the ability to function well on a physical, mental and social 
level. It can be measured in a reliable and valid manner by 
use of self-reported questionnaires, which can be categorised 
in three main groups; generic, disease specific and domain 
specific questionnaires. Generic questionnaires measure 
quality of life in general terms, independent of the presence 
of any disease. Disease specific questionnaires measure the 
consequences of a specific disease for the quality of life. 
Domain specific questionnaires focus on certain domains of 
quality of life, for instance physical inabilities.  
Depression 
Depression can be measured by use of a structured psy-
chiatric diagnostic interview (gold standard) after which the 
diagnosis can be made according to criteria of the Diagnostic 
and Statistical Manual of Psychiatric Disorders (DSM). 
However, these interviews are time consuming, therefore 
depression questionnaires were developed. These question-
naires are often used as a screening instrument for depressive 
symptoms, as a first step in the diagnostic process or as out-
come measures. Their validity is less than the diagnostic 
interview, but they do give an impression on the prevalence 
of depressive symptoms.  
Diabetes 
The gold standard to diagnose diabetes is an oral glucose 
tolerance test (OGTT). However, diabetes can also be diag-
nosed by measuring fasting glucose levels twice, as most 
physicians do today. Self-reported diabetes is a reliable 
measure of the presence of diabetes as well [9]. 
Effect Size 
We considered a <15%-point difference in quality of life 
between diabetic individuals with and without depressive 
symptoms as small, a 15 to 30%-point difference as moder-
ate, and a difference >30%-points as a severe difference.   
RESULTS 
The literature search yielded 496 studies. The titles of 
these 496 studies were screened for relevance, 354 studies 
were excluded as not relevant. Of the 142 remaining studies, 
31 were excluded because these were reviews, 5 were ex-
cluded because these were animal studies, 29 were interven-
tion studies comparing different treatments and 12 studies 
were only published as (meeting) abstracts. Of the 65 re-
maining studies the abstract and full text paper were 
screened. The large majority of studies (n=51) did not com-
pare quality of life measures in diabetic individuals with or 
without depression or depressive symptoms and were there-
fore excluded. We found 14 studies that did compare quality 
of life between diabetic individuals with and without depres-
sion or depressive symptoms. These 14 studies were in-
cluded in this review. From the reference lists of these stud-
ies we selected another 6 studies that met the inclusion crite-
ria. In total 20 studies were included in this review. 
Table 1 describes the study characteristics of the included 
studies. The majority of studies (18 out of 20) had a cross-
sectional design. Only two studies investigated the effect of 
depressive symptoms in diabetic individuals on quality of 
life in a prospective setting [10, 11]. Half of the studies did 
not discriminate between type 1 and 2 diabetes. All studies, 
except Goldney et al. [16], had a study sample of  100 
individuals with diabetes.  
Definitions of Depression, Diabetes and Quality of Life  
There is a large variation in the methods used to assess 
depression and depressive symptoms. Three studies used a 
standardised diagnostic interview (the gold standard) to as-
sess depression. All other studies used various questionnaires 
to assess depressive symptoms.  
Diabetes was mostly defined as diagnosed by a physi-
cian. Four studies used self-report to define diabetes.  
Quality of life was mainly determined by use of generic 
questionnaires. Generic quality of life was measured in thir-
teen studies. The Medical Outcomes Study 36-item Short 
Form Health Survey (SF-36) or an abbreviation of this ques-
tionnaire was used most frequently. The SF-36 contains 
eight multi item scales: physical function, role limitations 
due to physical health problems, bodily pain, general health 
perceptions, vitality, social functioning and role limitations 
due to emotional problems. The scores per item are linearly 
converted to a 0 to 100 scale, with higher scores indicating 
higher levels of functioning or well-being. Information on 
physical function, role physical, bodily pain and general 
health is combined into a physical components summary 
(PCS). Information on vitality, social functioning, role emo-
tional and mental health is combined into a mental compo-
nents summary (MCS). These summary scores are highly 
comparable between the SF-36 and the abbreviated versions 
of the SF. Diabetes specific quality of life was measured in 
only two studies [12, 13]. The questionnaires used focus on 
the impact and satisfaction of diabetes treatment and emo-
tional responses to having diabetes. Six studies evaluated 
quality of life by use of domain specific questionnaires, 
mainly Activities of Daily Living (ADL) and Instrumental 
Activities of Daily Living (IADL) questionnaires. ADL rep-
resent activities as washing your self, dressing yourself, eat-
ing and drinking, using the toilet etc. IADL represents activi-
ties as shopping, cooking meals, walking two or three 
blocks, walking up and down ten steps, doing light house-
work etc. 
The Association of Depressive Symptoms with Generic 
Quality of Life 
In general, most studies showed a moderate, negative as-
sociation of depressive symptoms on generic quality of life 
in individuals with diabetes [8, 12-22]. The majority of stud-
ies measured quality of both physical and mental health, al-
beit using different questionnaires. Five studies presented the 
absolute PCS scores [14, 16, 17, 20, 23], and four the MCS  114    Current Diabetes Reviews, 2009, Vol. 5, No. 2  Schram et al. 
 
Table 1. Studies Evaluating the Association between Depressive Symptoms and Quality of Life in Individuals with Diabetes 
Author  
(Publication Year) 
Country 
Study 
Design 
N Diabe-
tes 
Measure for 
Diabetes 
Type of 
Diabetes 
Measure 
for De-
pression 
Measure for Quality 
of Life 
Effect of  
Depressive 
Symptoms 
Generic Quality of Life 
Jacobson (1997) 
[12] 
US 
Cross-
sectional 
240 
Physician 
diagnosis 
1&2 
HSCL90
R 
SF-36 
Physical 
health 
–  Moderate 
Kohen (1998) [15]  UK 
Cross-
sectional 
100 
Physician 
diagnosis 
1&2  HADS  SF-28   –  Moderate 
Goldney (2004) 
[16] 
Australia 
Cross-
sectional 
97  Self-reported  1&2  PCEMD  SF-36 
Physical 
health 
Mental 
health 
– 
– 
Small 
Moderate 
Wexler (2006) [8]  US 
Cross-
sectional 
900 
Physician 
diagnosis 
2  HADS  Health Utility Index  –  Large 
McCollum (2007) 
[14] 
US 
Cross-
sectional 
1572 
Physician 
diagnosis 
1&2  ICD-9  SF-12 
Physical 
health 
Mental 
health 
= 
– 
No effect 
Small 
Hänninen (1999) 
[18] 
Finland 
Cross-
sectional 
222 
Physician 
diagnosis or 
fasting glu-
cose levels 
2  Zung DS  SF-20   –  Moderate 
Kaholokula (2003) 
[35] 
Hawaii 
Cross-
sectional 
146 
WHO criteria 
1999, c-
peptide 
2  CES-D  SF-36 
Physical 
health 
–  Moderate 
Ciechanowski 
(2000) [23] 
US 
Cross-
sectional 
367 
Physician 
diagnosis 
1&2 
HSCL90
R 
SF-12 
Physical 
health 
Mental 
health 
– 
– 
Small 
Small 
Sundaram (2007) 
[20] 
US 
Cross-
sectional 
385 
Physician 
diagnosis 
2  CES-D  SF-12 
Physical 
health 
Mental 
health 
– 
– 
Small 
Moderate 
Eren (2008) [22]  Turkey 
Cross-
sectional 
108 
Physician 
diagnosis 
2 
DSM IV, 
HRDS 
WHO QOL-BREF  –  Moderate 
Paschalides (2004) 
[19] 
UK 
Cross-
sectional 
184 
Physician 
diagnosis 
2 
Well-
Being 
Question-
naire 
SF-36 
Physical 
health 
Mental 
health 
– 
– 
Moderate 
Large 
Pawaskar (2007) 
[21] 
US 
Cross-
sectional 
792 
Physician 
diagnosis 
2  CES-D  SF-12   –  Moderate 
Bell (2005) [17]  US 
Cross-
sectional 
696 
Physician 
diagnosis 
1&2  CES-D  SF-12   –  Small 
Disease Specific Quality of Life 
Jacobson (1997) 
[12] 
US 
Cross-
sectional 
240 
Physician 
diagnosis 
1&2 
HSCL90
R 
DQOL   –  Large 
Hermanns (2006) 
[13] 
Germany 
Cross-
sectional 
376 
Physician 
diagnosis 
2  CIDI  PAID  –  –  Moderate Diabetes, Depression and Quality of Life  Current Diabetes Reviews, 2009, Vol. 5, No. 2    115 
 
Table 1. contd….. 
Author  
(Publication Year) 
Country 
Study De-
sign 
N Dia-
betes 
Measure for 
Diabetes 
Type of 
Diabetes 
Measure 
for De-
pression 
Measure for Quality 
of Life 
Effect of  
Depressive 
Symptoms 
Pouwer (2005) [36] 
The Nether-
lands, 
Croatia and 
UK 
Cross-
sectional 
539 
Physician 
diagnosis 
1&2  CES-D  PAID   –  Moderate 
Domain Specific Quality of Life 
Black (1999) [24]  US 
Cross-
sectional 
363 
Physician 
diagnosis 
2  CES-D 
ADL 
IADL 
 
– 
– 
Moderate 
Moderate 
Gregg (2002) [10]  US  Longitudinal  527  Self-reported  1&2  GDS 
Func-
tional 
limita-
tions 
–   Small 
Egede (2004) [25]  US 
Cross-
sectional 
1794  Self-reported  1&2  CIDI-SF 
Func-
tional 
limita-
tions 
  –  Moderate 
Bruce (2005) [11]  Australia  Longitudinal  1294 
Physician 
diagnosis 
2  GHS 
ADL 
Mobil-
ity 
 
– 
= 
Small 
No effect 
McCollum (2007) 
[14] 
US 
Cross-
sectional 
1572 
Physician 
diagnosis 
1&2  ICD-9 
ADL 
IADL 
Cogni-
tive 
limita-
tions 
Physi-
cal 
limita-
tions 
Self-
re-
ported 
health 
 
= 
= 
– 
– 
– 
No effect 
Small 
Moderate 
Moderate 
Small 
Pawaskar* (2007) 
[21] 
US 
Cross-
sectional 
792 
Physician 
diagnosis 
2  CES-D 
ADL 
IADL 
 
– 
– 
Unclassi-
fied 
Unclassi-
fied 
 negative association of depression with quality of life, = no effect.  
Depression questionnaires: HSCL90R, Hopkins Symptoms Checklist 90-Revised, HADS, Hospital Anxiety and Depression Scale, PCEMD, Primary Care 
Evaluation of Mental Disorders questionnaire, ICD-9, International Classification of Diseases 9th revision, Zung DS, Zung Self-Rated Depression Scale, CES-
D, Center for Epidemiologic Studies Depression Scale, DSM IV, Diagnostic and Statistical Manual of Mental Disorders VI, HRSD, Hamilton Rating Scale for 
Depression, CIS-R, Clinical Interview Schedule, GDS, Geriatric Depression Scale, CIDI-SF, Composite International Diagnostic Interview Short Form, GHS, 
General Health Status questionnaire. 
Quality of life questionnaires: SF-36, Medical Outcomes Study 36-item Short Form Health Survey, WHO QOL-BREF, World Health Organisation Quality of 
Life Assessment Brief version, DQOL, Diabetes Quality of Life Measure, PAID, Problem Areas in Diabetes, ADL, activities of daily life, IADL, instrumental 
activities of daily life.  
*This study had a longitudinal study design, but the association of depression with quality of life was investigated cross-sectionally. The longitudinal analyses 
evaluated the predictors of depression. Results in this study were reported as number of ADL or IADL limitations, and could therefore the effect size could not 
be classified.   
scores [14, 16, 20, 23] of the Short Form for diabetic indi-
viduals with and without depressive symptoms. These data 
are presented in Fig. (1) and show that diabetic individuals 
with depressive symptoms do consistently worse on both 
physical and mental health as compared to individuals with 
diabetes alone. These differences in both physical and men-
tal health were mild to moderate. The results suggest a simi-
lar strength of the associations between depressive symp-
toms and both physical and mental health (Fig. 1).  116    Current Diabetes Reviews, 2009, Vol. 5, No. 2  Schram et al. 
 
The four studies that used more extensive versions of the 
Short Form Health Survey (SF-20 to SF-36) allowed a com-
parison based on the subscales of the Short Form; physical 
function, role function, overall health, social function, pain 
and mental health [12, 15, 16, 18]. This comparison shows 
that depressive symptoms were most strongly associated 
with role function and social function (moderate to severely 
poorer scores, Table 2). Its associations with physical func-
tion, overall health and mental health were moderate, while 
pain was only mild to moderately lower among individuals 
with both depressive symptoms and diabetes.  
The Association of Depressive Symptoms with Diabetes 
Specific Quality of Life 
Four studies investigated the association of depressive 
symptoms with diabetes specific quality of life. These stud-
ies show a moderate to severely worse diabetes specific qual-
ity of life in the presence of depressive symptoms [12, 13, 
24, 36]. Individuals with both diabetes and depressive symp-
toms were less satisfied with their treatment, experienced a 
greater impact of the treatment, worried more about the im-
pact of diabetes in the future and about the social and voca-
tional impact of diabetes. In addition to these studies, Kohen 
et al. [15] investigated the association of depressive symp-
toms with the number of hypoglycaemic events and other 
symptoms of diabetes, but did not find any difference be-
tween diabetic individuals with and without depressive 
symptoms.  
The Association of Depressive Symptoms with Domain 
Specific Quality of Life 
Several studies have shown that both ADL and IADL are 
more impaired in diabetic individuals with depressive symp-
toms as compared to individuals with diabetes alone. Prob-
lems with ADL activities were reported more often by dia-
betic individuals with depressive symptoms as compared to 
individuals with diabetes alone. The difference in the preva-
lence of ADL problems between diabetic individuals with 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Difference in physical and mental health between diabetic individuals with and without depressive symptoms in studies using physi-
cal and mental components summary scores of the Short Form. * Significant difference between diabetic individuals with and without de-
pressive symptoms. Diabetes, Depression and Quality of Life  Current Diabetes Reviews, 2009, Vol. 5, No. 2    117 
 
and without depressive symptoms was mild to moderate, 
ranging from 4.2 to 16.9% [11, 14, 21, 25]. IADL was se-
verely worse in individuals with diabetes and depressive 
symptoms. The difference in prevalence of IADL problems 
between diabetic individuals with and without depressive 
symptoms was moderate, ranging from 13.3 to 27.6% [14, 
25]. Functional limitations as measured by Egede et al. [25] 
appeared to be closely related to IADL. Individuals with 
both depression and diabetes reported 20% more functional 
limitations than individuals with diabetes alone. McCollum 
[14] also reported on cognitive problems and self-reported 
health and showed that the individuals with both depression 
and diabetes more frequently had cognitive problems (differ-
ence 20%) and their self-reported health was 13% lower as 
compared to individuals with diabetes alone.  
Is Depression Causally Related to Functional Disability? 
Few studies investigated the association of depression 
and depressive symptoms with quality of life in individuals 
with diabetes in a prospective setting. We found only two 
longitudinal studies, that focussed on domain specific quality 
of life. These two studies investigated whether depressive 
symptoms can predict the development of functional limita-
tions in the future [10, 11]. Both studies show that depressive 
symptoms indeed predict the development of limitations in 
ADL and IADL activities. Individuals with depressive symp-
toms had a 41 to 89% increased risk to develop functional 
limitations. After multiple adjustments for behavioural and 
demographic confounders and co-morbidities, depression 
remained a significant predictor of problems with ADL ac-
tivities in one study [11], while the association disappeared 
in the other [10].  
Magnitude of the Effect of Depression on Quality of Life 
in Diabetes  
Wexler et al. compared the magnitude of the effect of 
depressive symptoms on quality of life in 909 individuals 
with diabetes directly with other factors that influence qual-
ity of life [8]. This study shows that depression was more 
strongly related to generic quality of life than microvascular 
complications, heart failure and the number of medications 
used.  
DISCUSSION 
This review shows that depressive symptoms in individu-
als with diabetes are associated with a worse quality of life. 
The majority of studies show that generic, diabetes specific, 
as well as domain specific quality of life are poorer in the 
presence of depressive symptoms. Generic and domain spe-
cific quality of life were mild to moderately reduced in dia-
betic individuals with depressive symptoms, while diabetes 
specific quality of life was moderate to severely worse. In 
addition, there is evidence that depressive symptoms can 
predict the development of functional limitations in the fu-
ture, suggesting a causal relationship between depressive 
symptoms and functional disability. 
All studies included in this review show a negative asso-
ciation of depressive symptoms with at least one aspect of 
quality of life in individuals with diabetes. The consistency 
of this finding strongly supports the hypotheses that indi-
viduals that have both depressive symptoms and diabetes 
have a worse quality of life than individuals with diabetes 
alone. However, we also found differences in the effect size 
of depressive symptoms on quality of life. These differences 
may be explained by the use of different instruments to 
measure depressive symptoms, diabetes and quality of life 
and possible differences in the perception of quality of life 
between countries and ethnic groups. 
Prospective studies on the association of depression and 
quality of life in individuals with diabetes are scarce. The 
available studies suggest that depression may indeed precede 
a decrease in quality of life [10, 11]. However, reversed cau-
sality, e.g. that a reduced quality of life or physical function 
in individuals with diabetes precedes the development of 
depressive symptoms, cannot be ruled out. Diabetes, depres-
sion and quality of life are closely interrelated. The causality 
and time path of these relations remains largely unknown. 
Evidence exists that diabetes is causally related to depression 
and vice versa. However, evidence on this area is weak. 
Therefore, longitudinal studies including estimates of diabe-
Table 2. Difference in Specific SF Scores between Diabetic Individuals with and without Depressive Symptoms from Four Studies 
that Used SF-20 to SF-36 
Percentage Lower SF-Score in Individuals with Diabetes and Depressive Symptoms 
as Compared to Individuals with Diabetes Alone  Author 
Jacobson (1997) [12]  Kohen (1998) [15]  Hänninen (1999) [18] Goldney (2004) [16] 
Range of Lower SF-
Score 
Effect Size 
Physical function  -17 *  -30 *  -17 *  -26 *  -17 to -30%  Moderate 
Role function  -28 *  -26 *  -100 *  -42 *  -26 to -100%  Moderate to severe 
Overall health  -27 *  -16 *  -17 *  -26 *  -17 to -27%  Moderate 
Social function  -19 *  -19 *  -40 *  -36 *  -19 to -40%  Moderate to severe 
Pain  -15 *  -4.4  -25 *  -24 *  -4 to -25%  Mild to moderate 
Mental health  -  -17 *  -20 *  -30 *  -17 to -30%  Moderate 
* SF-Scores were significantly lower among individuals with diabetes and depressive symptoms as compared to individuals with diabetes alone. Jacobson et 
al. and Goldney et al. used the SF-36, Kohen et al. the SF-28 and Hänninen et al. the SF-20. 118    Current Diabetes Reviews, 2009, Vol. 5, No. 2  Schram et al. 
 
tes, depression and quality of life are needed to elucidate 
their interrelations.  
Several factors are known to influence both depressive 
symptoms and quality of life, including age, sex, marital 
status, educational level or income. These factors may con-
found the association between depressive symptoms and 
quality of life. About half of the studies evaluated here did 
not take these factors into account by adjusting for them in 
statistical analyses. However, the studies that did take these 
factors into account, did not demonstrate large effects on the 
association between depressive symptoms with quality of 
life [8, 10-12, 14, 18, 21, 25]. This may suggest that the as-
sociations presented here will not be largely confounded by 
these factors. However, confounding is a major issue in epi-
demiology. The observation that about half of studies did not 
adjusted their analyses for confounding factors suggests that 
more elaborative studies on this subject are warranted.    
Both physical and mental quality of life scores were re-
lated to depressive symptoms. One may argue that psychiat-
ric status is per definition related to mental health. Some 
studies indeed excluded the mental component of their qual-
ity of life questionnaire for this reason [12, 26]. 
Next to the considerable effect of depression on quality 
of life in individuals with diabetes, as demonstrated by this 
review, depression also contributes to poor self-care, poor 
adherence to medical treatment, higher rates of medical mor-
bidity and mortality and increased health-care costs [23, 27-
30]. Several studies have shown that glycemic control is 
worse in diabetic individuals with as compared to those 
without depressive symptoms [31]. In addition to this, the 
presence of depressive symptoms is also related to worse 
diabetes self-care, reflected by a worse adherence to diet and 
exercise advice, use of oral glucose lowering medication and 
frequency of glucose monitoring [23, 26, 37, 38]. Currently, 
the causality of these associations is not known since all 
studies are based on cross-sectional data. However, one 
study evaluated whether a stepped care approach for depres-
sive symptoms in individuals with diabetes improved self-
care. However, despite an improvement of depressive symp-
toms that exceeded the effect of usual care, no effect on self-
care could be observed [37]. This study stresses the impor-
tance of an integrated diabetes care approach that addresses 
both the practical and emotional issues in diabetes.   
The presence of depression thus has major consequences 
for individuals with diabetes. However, several studies have 
shown that depression can be well treated in individuals with 
diabetes [32, 33]. Altogether, this review stresses the impor-
tance for intervention when individuals with diabetes present 
with depressive symptoms. However, only a small percent-
age of diabetic individuals is currently being recognised as 
being depressed in primary and secondary medical care set-
tings [34]. Therefore, increased awareness for depression in 
diabetes care is needed. This can be achieved by including 
screening instruments for depression as part of regular diabe-
tes care [13]. 
In conclusion, this review shows that higher levels of de-
pressive symptoms are associated with an impaired quality 
of life in individuals with diabetes. Diabetes specific quality 
of life is severely lower among individuals with diabetes and 
depressive symptoms. Depressive symptoms may even pre-
dict the development of functional limitations. As a conse-
quence, depressive symptoms jeopardize the ability of dia-
betic individuals to take care of themselves. Therefore, 
screening for and monitoring of depressive symptoms should 
be integrated in standard diabetes care. Furthermore, as most 
studies on this subject have a cross-sectional design; it is 
difficult to infer conclusions regarding the causality of the 
associations. More prospective studies are therefore needed 
to elucidate the causality of the association between depres-
sive symptoms and quality of life in individuals with diabe-
tes.  
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